Home/Filings/4/0001181431-12-060719
4//SEC Filing

Lindblom Christopher M 4

Accession 0001181431-12-060719

CIK 0001113148other

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 6:27 PM ET

Size

12.6 KB

Accession

0001181431-12-060719

Insider Transaction Report

Form 4
Period: 2012-11-26
Lindblom Christopher M
Controller & Asst. Treasurer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2012-11-2610,00010,000 total
    Exercise: $14.33Exp: 2016-10-26Common Stock (10,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2012-11-263,8850 total
    Exercise: $9.80Exp: 2017-12-13Common Stock (3,885 underlying)
  • Sale

    Common Stock

    2012-11-26$25.73/sh13,885$357,2720 total
  • Exercise/Conversion

    Common Stock

    2012-11-26$14.33/sh+10,000$143,30010,000 total
  • Exercise/Conversion

    Common Stock

    2012-11-26$9.80/sh+3,885$38,07313,885 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    2,158
Footnotes (3)
  • [F1]Represents 2,158 shares of Infinity Pharmaceuticals, Inc. common stock acquired under the Infinity Pharmaceuticals, Inc. 401(k) plan.
  • [F2]This option was fully vested with respect to all 20,000 shares subject to the option as of the date hereof.
  • [F3]This option was fully vested with respect to all 3,885 shares subject to the option as of the date hereof.

Issuer

INFINITY PHARMACEUTICALS, INC.

CIK 0001113148

Entity typeother

Related Parties

1
  • filerCIK 0001378796

Filing Metadata

Form type
4
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 6:27 PM ET
Size
12.6 KB